SCIRP Mobile Website
Paper Submission

Why Us? >>

  • - Open Access
  • - Peer-reviewed
  • - Rapid publication
  • - Lifetime hosting
  • - Free indexing service
  • - Free promotion service
  • - More citations
  • - Search engine friendly

Free SCIRP Newsletters>>

Add your e-mail address to receive free newsletters from SCIRP.


Article citations


Tournigand, C., Samson, B., Scheithauer, W., Lledo, G., Viret, F., Andre, T., et al. (2012) Bevacizumab (Bev) with or without Erlotinib as Maintenance Therapy, Following Induction First-Line Chemotherapy plus Bev, in Patients (pts) with Metastatic Colorectal Cancer (mCRC): Efficacy and Safety Results of the International GERCOR DREAM Phase III Trial. Journal of Clinical Oncology, 30, Article ID: LBA3500.

has been cited by the following article: